National Research ( (NRC) ) has released its Q4 earnings. Here is a breakdown of the information National Research presented to its investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
National Research Corporation, operating as NRC Health, is a leader in humanizing healthcare services by providing insightful market research and understanding consumer preferences in the healthcare sector. In the fourth quarter of 2024, NRC Health reported a slight decline in revenue to approximately $36.9 million from $38.0 million the previous year, alongside a decrease in earnings per diluted share from $0.36 to $0.28. The company maintained its strategic focus on shareholder returns, repurchasing 393,000 shares for around $7.3 million and distributing $2.8 million in dividends. Despite a decline in revenue and net income, NRC Health continues to show robust recurring contract value at $133.2 million, demonstrating its continued relevance and engagement in the healthcare market. The management remains focused on its strategic initiatives to drive growth and enhance shareholder value while navigating market challenges.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue